About Nventa Biopharmaceuticals

Nventa Biopharmaceuticals Corp and Akela Pharma Inc merged on May 21, 2009.

Akela is an integrated product development company primarily focused on therapeautics for pain utilizing proprietary drug delivery technologies. Akela's lead product candidate is Fentanyl TAIFUN, a fentanyl formulation specifically designed to be delivered with Akela's TAIFUN Multi-Dose Inhaler.

Facts about Nventa Biopharmaceuticals
  • Focus : Manufacturer
  • Industry : Pharma

Product portfolio of Nventa Biopharmaceuticals

News about Nventa Biopharmaceuticals

Here you will find Nventa Biopharmaceuticals Corporation

See the theme worlds for related content

Topic world biopharmaceutical manufacturing

Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.

20+ products
15+ brochures
View topic world

Topic world biopharmaceutical manufacturing

Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.

20+ products
15+ brochures